49 day74-Elections in America 美国的选举 04:47 day75-Loud about quiet quitting 躺平 05:27 day76-Policing in America 美国的治安 04:23 day77-Your inner dawdler 拖延症 04:52 day78-Monkeypox medicines 猴痘药物 03:10 day79-Medicine and the brain 医学与大脑 03:34 day80-Digital advertising ...
In a personal view published today, a general practitioner says that the new targets for diagnosing dementia will lead to more harm than good. The government is putting pressure on commissioners, and in turn general practitioners, to make more diagnoses of dementia, but no analysis has been done...
The invention discloses a new medicine application of a traditional Chinese medicinal composition in preparing a medicine for treating vascular dementia. The traditional Chinese medicinal composition consists of the following crude medicines: 170-510 parts of uncaria rhynchophylla, 150-450 parts of ...
With respect to the economic incentives necessary for the substantial R&D investments required to discover new medicines, we can attest that these still exist for psychiatric drugs, especially if new and improved versions can be developed. In fact, the limited “effect sizes“ (poor overall efficacy...
The questionnaires asked people if they wake up in the middle of the night, cannot fall asleep within 30 minutes, feel too hot or cold in bed, or take medicines to help them sleep. To measure daytime sleepiness, the researchers asked participants how often they have difficulty staying awake ...
Drug approval information can be found on the EMA official website, as follows: https://www.ema.europa.eu/en/medicines/human/EPAR/opzelura CMS Disclaimer and Forward-Looking Statements This press release is not intended to promote any pro...
approach called "functional metagenomics" for developingnew medicines. It opens the possibility of sustaining health and treating disease with medicines and other substances that target non-human cells in the body. The article notes that many substances intraditional Chinese medicinesmay work in that ...
The medicines remove amyloid from the brain. But these drugs only work in the early part, or stage, of Alzheimer’s progression. Few patients get the costly brain scans and invasive spinal taps that could show early stage Alzheimer’s. 新药如Leqembi和Kisunla可以稍微减缓疾病的发展。这些药物...
Despite this, the US Food and Drug Administration has licensed two such drugs. The European Medicines Agency (EMA) has recommended rejecting one (lecanemab) predominantly on the grounds that the small effects seen do not outweigh the risk from side effects; it is reviewing the other. The UK...
activity," says senior author Lipton, who is also the Step Family Foundation Endowed Professor and co-director of the Neurodegeneration New Medicines Center at Scripps Research. "But the beauty of this method is that it lets us uncover novel targets for Alzheimer's disease and related dementias....